A study for a 72 year old man who takes Valsartan, Eliquis, Amiodarone Hydrochloride (an AI-powered real world drug study)

Summary:

2,356 males aged 72 (±5) who take the same drugs and have adverse effects are studied. This is a phase IV clinical study for a 72 year old male patient who has A-Fib, High Blood Pressure. The study is created by eHealthMe based on reports from sources including the FDA.

On Sep, 16, 2025

2,356 males aged 72 (±5) who take Valsartan, Eliquis, Amiodarone Hydrochloride and have adverse effects are studied.

Number of reports submitted per year:

Valsartan, Eliquis, Amiodarone Hydrochloride for a 72-year old man.

Information of the patient in this study:

Age: 72
Gender: male
Conditions: A-Fib, High Blood Pressure
Drugs taken:
- Amiodarone Hydrochloride (amiodarone hydrochloride)
- Eliquis (apixaban)
- Valsartan (valsartan)

Common drug interactions *:

Dyspnea (difficult or laboured breathing): 208 people, 8.83%
Fatigue (feeling of tiredness): 144 people, 6.11%
Weakness : 144 people, 6.11%
Hypotension (abnormally low blood pressure): 137 people, 5.81%
Cardiac Failure : 119 people, 5.05%
Dizziness : 113 people, 4.80%
Diarrhea : 112 people, 4.75%
Pneumonia : 112 people, 4.75%
Death : 105 people, 4.46%
Anaemia (lack of blood): 100 people, 4.24%
Fall : 98 people, 4.16%
Pain : 94 people, 3.99%
Acute Kidney Failure : 91 people, 3.86%
Weight Decreased : 90 people, 3.82%
Interstitial Lung Disease : 83 people, 3.52%
Drug Ineffective : 76 people, 3.23%
Cardiac Failure Congestive : 71 people, 3.01%
Fever : 70 people, 2.97%
Malaise (a feeling of general discomfort or uneasiness): 69 people, 2.93%
Oedema Peripheral (superficial swelling): 68 people, 2.89%

Common co-existing conditions *:

You may use this to check any potential undetected conditions.

Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 387 people, 16.43%
Multiple Myeloma (cancer of the plasma cells): 151 people, 6.41%
Cardiac Failure : 127 people, 5.39%
Pain : 122 people, 5.18%
High Blood Cholesterol : 117 people, 4.97%
Type 2 Diabetes : 96 people, 4.07%
Diabetes : 76 people, 3.23%
Cardiac Disorder : 68 people, 2.89%
Dyslipidaemia (abnormal amount of lipids): 54 people, 2.29%
Gout (uric acid crystals building up in the body): 52 people, 2.21%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 50 people, 2.12%
Hyperlipidaemia (presence of excess lipids in the blood): 47 people, 1.99%
Cardiac Failure Chronic : 47 people, 1.99%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 45 people, 1.91%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 44 people, 1.87%
Nausea (feeling of having an urge to vomit): 43 people, 1.83%
Constipation : 43 people, 1.83%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 43 people, 1.83%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 43 people, 1.83%
Prostate Cancer : 37 people, 1.57%

Common co-used drugs *:

You may use this to check any potential interacting drugs.

Drug effectiveness *:

Valsartan:

not at all: 0 %
somewhat: 0 %
moderate: 50 %
high: 0 %
very high: 50 %

Eliquis:

not at all: 0 %
somewhat: 0 %
moderate: 0 %
high: 50 %
very high: 50 %

Amiodarone Hydrochloride:

not at all: 0 %
somewhat: 33.33 %
moderate: 33.33 %
high: 0 %
very high: 33.33 %

* Some reports may have incomplete information.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Drug side effects in long term, by gender and age:

Amiodarone hydrochloride: 10,053 reports
Eliquis: 191,768 reports
Valsartan: 63,785 reports

Treatments, associated medications and conditions:

A-fib: 349,112 reports
High blood pressure: 1,062,468 reports

Drug interactions:

How the phase IV clinical study uses the data?

The study is based on gender, age, active ingredients of any drugs used. Other drugs that have the same active ingredients (e.g. generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.